The Rockefeller University Executive and Leadership Team

Devin Brosseau, the Managing Director, Investments & Chief Operating Officer at The Rockefeller University, directs the financial strategy and operational infrastructure supporting biomedical research. Managing Director, Investments & Chief Operating Officer Brosseau oversees the endowment portfolio to ensure long-term funding for scientific inquiry. By optimizing administrative workflows, Brosseau improves the efficiency of laboratory operations across the campus. This leadership role involves coordinating with academic departments to align fiscal resources with research priorities. Brosseau drives North American investment initiatives while maintaining rigorous standards for institutional growth. Through the management of complex financial assets, Brosseau secures the necessary capital for groundbreaking discoveries. The operational oversight provided by Brosseau ensures that the university maintains a competitive edge in the global research landscape. By streamlining internal processes, Brosseau supports the mission of the university to advance human health through innovative scientific exploration and discovery.

Abigail Rockefeller, the President at The Rockefeller University, architects the overarching vision for biomedical research and academic excellence. As the President, Rockefeller defines the strategic direction for graduate programs and faculty recruitment. This leadership role involves fostering partnerships with global research institutions to expand the reach of scientific inquiry. Rockefeller drives initiatives that prioritize interdisciplinary collaboration, ensuring that the university remains at the forefront of medical innovation. By engaging with the Board of Trustees, Rockefeller secures support for large-scale research projects. Abigail Rockefeller also oversees the development of state-of-the-art laboratory facilities to accommodate evolving scientific needs. Through the promotion of rigorous academic standards, Rockefeller maintains the reputation of the institution as a leader in the biomedical field. The strategic guidance provided by Rockefeller ensures that the university continues to produce transformative research that addresses critical health challenges on a global scale.

Esther Lederberg, the President at The Rockefeller University, directs the expansion of specialized biomedical research programs and academic curriculum development. As the President, Lederberg focuses on cultivating a diverse environment for graduate students and postdoctoral researchers. This leadership role involves managing the integration of new technologies into existing research frameworks to enhance experimental capabilities. Lederberg drives efforts to increase the visibility of the university within the international scientific community. By collaborating with department heads, Lederberg ensures that research objectives align with the broader mission of the institution. Esther Lederberg also oversees the implementation of professional development programs for faculty members to support career growth. Through the management of academic resources, Lederberg facilitates the discovery of novel biological mechanisms. The leadership provided by Lederberg strengthens the commitment of the university to excellence in graduate education and the pursuit of fundamental scientific knowledge.

Richard Lifton, the President at The Rockefeller University, architects the long-term research agenda and institutional growth strategies. As the President, Lifton oversees the recruitment of world-class scientists to lead high-impact research groups. This leadership role involves managing the allocation of research grants and internal funding to support innovative projects. Lifton drives the development of collaborative networks that bridge the gap between basic science and clinical application. By engaging with external stakeholders, Lifton promotes the value of biomedical research in addressing public health crises. Richard Lifton also directs the modernization of research infrastructure to support advanced genomic and molecular studies. Through the oversight of academic policies, Lifton ensures that the university maintains a rigorous and ethical research environment. The strategic vision provided by Lifton empowers the institution to tackle complex biological questions and contribute significantly to the advancement of medical science.

Michael Young, the President at The Rockefeller University, directs the strategic focus on fundamental biological research and institutional innovation. As the President, Young oversees the alignment of research priorities with the evolving needs of the biomedical field. This leadership role involves fostering an environment that encourages high-risk, high-reward scientific inquiry. Young drives the expansion of research facilities to support cutting-edge investigations into cellular and molecular processes. By working closely with the faculty, Young ensures that the university remains a hub for intellectual discovery and academic freedom. Michael Young also manages the outreach efforts to communicate the impact of research findings to the broader public. Through the oversight of institutional governance, Young maintains the integrity and excellence of the graduate programs. The leadership provided by Young ensures that the university continues to push the boundaries of knowledge and train the next generation of scientific leaders.